chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few days after the first dose, I began to be very tired and it lasted about 6 months and couldn't get out of bed and couldn't think. I felt worse than when I had mono. I had "brain fog" for about 6 months. Malaise, fatigue was very bad. A few days before my cycle I had severe menstrual cramps and this continued for the next three months before my cycle.  Since I have a IUD my cycle used to be regular all the time, but now it is irregular and heavier than it used to be. This is still happening today.
Pt received a combo of HEP B, POLIO, DTaP  vaccine: HEP B (RECOMBINANT) & PEDIARIX  pt was suppose to receive the HEP B 3rd dose vaccine.
tested positive for COVID-19 after vaccination; flu like/cold like symptoms; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like/cold like symptoms) and COVID-19 (tested positive for COVID-19 after vaccination) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like/cold like symptoms). On 12-Feb-2021, the patient experienced COVID-19 (tested positive for COVID-19 after vaccination). On 12-Feb-2021, INFLUENZA LIKE ILLNESS (flu like/cold like symptoms) had resolved. At the time of the report, COVID-19 (tested positive for COVID-19 after vaccination) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications reported were Medication for hypertension. No treatment information was provided.
10 minutes after receiving her first dose of Covid vaccine, patient felt dry, itchy throat and had a dry cough. She was brought to us by EMS staff for medical evaluation. BP was elevated. Denies any other symptoms. Face slightly flushed, chest CTA, RRR, able to communicate well, A&O. BP 184/115 left arm, repeat after 10 minutes: 164/102. has hypertension and took her med today.  Symptoms resolving and after approx 20 minutes, completely resolved. Patient declines to be transferred to local healthcare facility and agreed to call her PCP once she returned home to notify of BP and possible reaction to vaccine. Feeling much better, she stated her husband was here and she was going home.
Itchiness developed on left side of upper back. On 11/05/2011, a vesicular rash was noted in the area. Shingles was diagnosed by the doctor on 11/07/2011.
Rash developed on upper torso / persisted and gotten worse / entire torso, from and back; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd November 2020, the patient received Shingrix. On 23rd December 2020, 30 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. Age group was not reported but captured as adult as per vaccine indication. A rash developed on upper torso. The rash had persisted and gotten worse.  It now covered entire torso, from and back of the patient.  The reporter asked was this normal, and asked about recommendation.
Pt was vaccinated. She said she felt fine. Pt walked 15 feet then fainted. Her mom was able to catch her. We moved her to a cot. She slowly regained consciousness. She had no signs of anaphylaxis. She was breathing fine. Her mother states she has fainted during blood draws in the past and her daughter hadn't eaten this morning. We monitored pt for 30 minutes. Her color and smile came back. Pt was able to walk out on her own. Her mother will monitor her today.
Rash starting 4/5/14 - not yet resolved. Fever starting 4/14/14.
Patient experienced a hard time breathing while in the waiting room, after receiving his first dose of the Moderna COVID vaccine. He approached the pharmacy counter and was gasping for air. Pharmacist and tech helped him to the waiting area so he could sit. Upon quick evaluation, patient was pale, sweating and panting. Pharmacist immediately gave him epinephrine 0.3mg injection, and the store manager called 911. After a couple of minutes, patient was able speak and breathe easier. Patient regurgitated and stated he felt much better. The ambulance arrived 15 minutes afterwards and the paramedics checked his vitals (good pulse and blood pressure). Patient was then transported to the local hospital for observation.
Patient developed loss of taste 1 day after vaccine, still present on 10/19/2021
Since receiving the vaccine I have had increasingly painful joint pain.  I have had shoulder pain in the past and the pain in the shoulder/ muscle has gotten worse. I also have new and sometimes severe pain in the elbows, wrists, knees and ankles.  Pain in these areas is new and after exercise the pain tends to be the worst.
NO fever at all during this time or shortness of breath. Pain in the  arm at injection site up into neck and top of head. (48 hours) Tylenol for pain.   About 3pm Saturday 2/6: Concerning spike of blood pressure 154/92-resulted in urgent care visit. Covid test taken as precaution by MD. Mom not "feeling well"  0630 Sunday 2/7:  BP spike to 166/109, Blurry vision, dizziness. EMS called to assess at home. followed up by ER visit. all tests resulted negative. BP dropped to 120/72.  On discharge BP up to 162/92. Lisinopril prescribed for HBP. 1 dose given.  Monday 2/8: Vomiting and diarrhea, lightheaded. EMS called for assessment, BP drop 100/70. Hydration, rest.  Moderate/Severe fatigue and aches  (6-7 days)  Mild lethargy. (24-36 hrs)
Patient had a severe  hypoglycemic reaction in the early morning hours 6 days after vaccination.  She had not changed her insulin dose or time or diet. This required a visit by ambulance to the local hospital.
8 pm on 4/3 -- > Chills, intense aches and pains, migraine Continued until 10 am on 4/4 10 am to 6 pm on 4/4 -- > mild aches and pains, sore arm 6 pm+ on 4/4 -- > intense aches and pains, sore arm
Woke at 1 am with chills, fever and severe headache. Chills subside after 45 minutes. Woke at 4 am with severe headache and 102 degree fever. Headache and fever resolved approximately 7 am.
Patient stated that she developed teeth chattering chills, causing her arms to shake. She took an aspirin and went to bed. She stated that the next day she was sluggish but better. The injection site was examined and was void of redness and swelling.
As the treating physician, I did not witness the shot given in the immunization clinic. From the parent report, pt was very apprehensive and crying and screaming during the Hepatitis A shot. The family walked to the car and mother carried him most of the way.  She placed him in his seat and noticed that he had tensed up and would not respond to her questions. If he had any convulsions, it may have lasted 10 seconds. By the time she brought pt back into the clinic, he was back to his normal state. We checked his vitals and assessed him within 2 minutes of the event. No neurological sequelae afterwards. In my medical opinion, it's very difficult to say with certainty that he did have a true seizure. This possibly could have been some mytonoic reaction due to fatigue after receiving his shots or a behavioral issues as well. There was no fecal or urinary incontience.  No clear h/o eye deviation. No tongue biting.
eosinophilic pneumonia with associated hypoxia, pneumothorax, and bilateral pulmonary emboli.
RED, HARD, PAINFUL BUMP AT  INJECTION SITE; This spontaneous report received from a consumer concerned a 48 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included lupus, peanuts / all nuts allergy, and apple/pears allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced red, hard, painful bump at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red, hard, painful bump at injection site. This report was non-serious.
Headache wouldn't go away. On 3rd day ended up in E.R. via ambulance with severe headache and chest pains.
Headache awakening me during night immediately after vaccine, malaise next day but not incapacitating. Sore arm with redness and firmness for one week after injection, just below injection site.
1-12-21 Resident is complaining of heart pain. Resident blood pressure is 228/105.  1-22-21 Dx UTI 1-13-21     His nurse called MD at approximately 0645, reported to him that it was reported to this nurse that resident has not slept in 2 days and night, has an increased blood pressure, reports severe pain in lower back, and appears to be uncomfortable Resident is able to verbalize his pain and where it is at, but is unable to explain the quality of the pain or give a number on the 0/10 pain scale.
Son developed high fever, inflamed ears, severe rash, agitation, sleeplessness, soreness, runny nose and a cough 5 days following shot. Fever lasted 3-4 days, followed by rash 2-3 days. 3 weeks following son now has swollen lymph nodes in neck and groin region. Mild agitation from discomfort. Son still will not sleep more than 45 mins at a time and now snores since receiving injection.
Series of events happened between 11am-11:15am: Pt said he was feeling warm and was sweating. I asked tech for bottle of cold water/thermometer and gave water to pt and took a temp from forehead. It read 94.4F twice.  I asked if he had problems swallowing and he said he could swallow. He took one or two sips and then he started talking and suddenly stopped. He begin to mildly shake just enough to spill his water on his lap and the floor and as I went to grab it, he dropped the open bottle. He seemed as if he was having a mild seizure sitting upright with eye partially closed. I called for tech help with someone calling 911 and someone giving me napkins to catch the water. The patient came to within a minute or so and started talking to me that he's feeling better. Store management showed up. I asked the tech to go get me the blood pressure monitor. I asked patient his name, if he had diabetes, high blood pressure or on any medications. He said no and he was on his way to work. He didnt realize anything just happened. That's when EMT took over the scene.
1. Cough  2. Suspected COVID-19 virus infection  3. Nasal congestion with rhinorrhea  4. Shortness of breath  5. Sinus congestion  6. Acute non-recurrent frontal sinusitis
36 hours after injection, experienced severe, debilitating vertigo that last 3 days.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included montelukast sodium (SINGULAIR) and salbutamol (ALBUTEROL) from an unknown date for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205,) via an unspecified route of administration in the right arm on 10 Mar2021 at 08:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 20:30, 36 hours after injection, the patient experienced severe, debilitating vertigo that lasted 3 days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the severe debilitating vertigo. The clinical outcome of the event severe, debilitating vertigo was recovered on 04Apr2021.   No follow-up attempts are needed. No further information is expected.
Headache and mild nausea after 2nd dose, starting at about 21hrs post and lasting about 12hrs.
No Adverse event; Patient received Moderna Bivalent Booster 0.25mL dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received Moderna Bivalent Booster 0.25mL dose) and NO ADVERSE EVENT (No Adverse event) in a 51-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 13-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received Moderna Bivalent Booster 0.25mL dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received Moderna Bivalent Booster 0.25mL dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received Moderna Bivalent Booster 0.25mL dose).    Concomitant medications details were not reported by the reporter.  Treatment details were not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 17-Oct-2022: Follow-up document contains updated batch number of suspect product.
pt about 15 minutes after vaccine told us he was not feeling well. we had him sit back down, gave him water, and checked his blood pressure. it was 180/85 and then around the same when checked We ended up calling 911 and he went to hospital. Pt did state he has high blood pressure.
1108  RN  responded to vehicle 2 pt c/o lightheadedness. also c/o nausea and throat burning. NKA, c/o pressure in her head- pain 3 out of 10  1110: BP -114/78, p-62, R-17. No apparent distress noted, speaking and difficulty.  see progress note
Began to have itching on the bottom of my right foot, swelling began, red rash started, and foot became painful to walk on.  The following morning I awoke to the rash spreading up between my toes on my right foot, and both of my palms were red and itch, and my fingers were swollen.  There was a continuous tingling feeling in my hands and right foot, and when my fingers and toes needed to be moved to walk or hold something, the feeling was that of an extreme sunburn.  By evening, the rash had spread up between my fingers, and it began spreading up my forearm.  By the 2nd day, the rash and itching had started on my left foot. I saw my family doctor on the 3rd day and received a prednisone shot and a course of prednisone pills.  They helped some, but now on day 6, I am still itching, but the redness and pain has mostly subsided.
This is a spontaneous report from a contactable pharmacist. A 65-year-old female patient received PREVNAR 13, via an unspecified route of administration on 13Oct2017 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. One month later (13Nov2017), she had hives all over her body which lasted for 9 months. The patient recovered from the event in Jul2018. The information on the lot number and expiration will be requested.
Extreme pain left shoulder, burning and radiant feeling. It lasted for 2 days. I went to urgent care facility, got X-rays and ekg, results were normal.  Pain was onset by a common cold, sore throat and aphonia.
Vision blurred/ eyes to be blurred; This is a spontaneous report from a non-contactable consumer (patient's parent). A female patient of an unspecified age received second dose of BNT162B2 (Lot Number: Unknown), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter informed reporter's daughter got a COVID Vaccine for Pfizer's second dose and her 'visual' (not clarified) vision is blurred, she went to all the eye doctor and they can't figure it out what was going on, so she need to understand what you guys have in that vaccine that was causing her eyes to be blurred and she can't understand, read or write or anything. Reporter stated they were dealing with serious things. The outcome of events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Information has been received from a physician's office concerning a 3 year old male who on 5/5/97 (lot #10024 invalid) was vaccinated with MMRII. In 11/98, the pt was dx'd with autism. The pt's mother believed that the autism was "due to" vaccination with MMRII. Upon internal review, autism was determined to be an "Other Medical Event". On 4/5/99, (lot #0759 invalid) was vaccinated with a 2nd dose of MMRII. The pt had transferred to this practice. Additional information has been requested. The follow-up states on 07/07/1998 the pt was sent at a genetic clinic and had a genetic test done which was normal and a fragile X test was also normal. on 11/11/1998, a pediatric neurologist reported "that the pt appears to have autism." On 12/12/1998 another physician and psychologist reported that "the child was slow to progress, in the intermediate school district." The pt's mother believed that the autism was "due to" vaccination with MMR vaccine. Upon interal review, autism was determined to be an other medical event. On 04/05/1999 the pt was vaccinated with a second dose of MMR vaccine. The pt transferred to a different practice. Upon internal review, autism was determined to be an other medical event. No further info is expected. F/U states: vaccinated with MMRII, in the left thigh (lot 620094/1334D) (lot 619063/0228D-diluent vail); Hep-B (ENG2283A2) in the right thigh. On 7/798, the pt was seen at a genetic clinic and had a genetic test done which was normal and a fragile X test wasl also normal. In 11/98, the pt was dx'd with autism. On 11/11/98, a pediatric neurologist reported "that the pt appears to have autism". On 12/12/98, another physician and psychologist reported that "the child was slow to progress, in the Intermediate School District". The pt's mother believed that the autism was "due to" vaccination with MMRII. Upon internal review, autism was determined to be an "Other Important Medical Event". On 4/5/99, the pt was vaccinated with a 2nd dose of MMRII (lot 0759-invalid). The pt transferred to a different practice. F/U from the physician's office idicated that there were no reported adverse experiences and that suspected autism was considered to be a pre-existing condition. No further information is expected.
Patient began noticing pain and swelling at the injection site almost immediately afterwards.  The pain and swelling escalated to the point of involving soft tissue on the deltoid, axilla, ribs and pectoral region of the chest.  He also is experiencing lymphadenitis.  The entire area appears red and inflamed, but he is not febrile.
deathly ill; Initial information received on 26-Oct-2021 regarding an unsolicited valid non-serious case from a consumer or non-healthcare professional via social media.  This case involves patient (unknown demographics) who was deathly ill (illness) after receiving INFLUENZA VACCINE.  The patient's past medical treatment, vaccination and family history, concomitant medication were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious deathly ill (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported ''Last 2 flu shots I got made me deathly ill, have not had one in over 8 years and have not been sick once. I have also been exposed to Covid by a lot of people who had it when I was exposed to them and nothing. My immune system is working just fine.''  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event (deathly ill).  The event outcome was unknown for illness.  There will be no information available on the batch number for this case.
Complaining of arms, legs and back hurting, chronic cough developed. Doctors still don't know what's wrong. She gets paroxysmal cough, may last to up 15 hrs, does not respond to any cough syrups at least 5 ER visits in one year. The annual follow up states she still has coughing attacks and they still give her Vicatin and steroid shots to stop the paromaxal coughing.
first dose/on 09/15/2018/never received one; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 15th September 2018 on left arm into the muscle).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details provided were as follows: The reporter was the patient herself. The age at vaccination was not applicable for this report. The patient received her 1st dose of Shingrix and did not know about the second dose of Shingrix to complete the series, so till the time of reporting she did not receive the 2nd dose, which led to incomplete course of vaccination. The reporter did not have lot number and expiration date for Shingrix. She had national drug code number (58160-0819-12). VAERS details for 1st dose was reported. The reporter gave a consent to follow-up with health care professional. However, she did not have a fax number or an email address. The reporter consented to follow up. This case has been linked with US2021156427, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021156427:Same reporter. Husband case.